News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
13,101 Results
Type
Article (738)
Company Profile (19)
Press Release (12344)
Section
Business (4471)
Career Advice (17)
Deals (650)
Drug Delivery (2)
Drug Development (2327)
Employer Resources (2)
FDA (208)
Job Trends (273)
News (7199)
Policy (377)
Tag
Academia (37)
Adcomms (3)
Allergies (5)
Alliances (1209)
ALS (1)
Alzheimer's disease (10)
Antibody-drug conjugate (ADC) (9)
Approvals (201)
Artificial intelligence (5)
Bankruptcy (4)
Best Places to Work (218)
BIOSECURE Act (5)
Biosimilars (1)
Biotechnology (15)
Bladder cancer (1)
Cancer (59)
Cardiovascular disease (7)
Career advice (10)
CAR-T (9)
Cell therapy (31)
Clinical research (1785)
Collaboration (31)
Compensation (18)
COVID-19 (103)
CRISPR (4)
C-suite (11)
Cystic fibrosis (1)
Data (54)
Diabetes (3)
Diagnostics (31)
Drug discovery (2)
Drug pricing (1)
Earnings (1416)
Editorial (2)
Employer resources (2)
Events (2413)
Executive appointments (37)
FDA (237)
Funding (30)
Gene editing (8)
Gene therapy (21)
GLP-1 (17)
Government (48)
Guidances (2)
Healthcare (384)
Immunology and inflammation (5)
Infectious disease (104)
Inflammatory bowel disease (7)
Intellectual property (4)
Interviews (3)
IPO (358)
Job creations (62)
Job search strategy (10)
Kidney cancer (1)
Labor market (4)
Layoffs (14)
Legal (64)
Liver cancer (1)
Lung cancer (6)
Lymphoma (11)
Machine learning (1)
Management (1)
Manufacturing (10)
MASH (1)
Medical device (63)
Medtech (63)
Mergers & acquisitions (305)
Metabolic disorders (7)
Neurodegenerative disease (5)
Neuroscience (19)
NextGen: Class of 2025 (138)
Non-profit (19)
Now hiring (1)
Obesity (3)
Opinion (1)
Ovarian cancer (1)
Pain (6)
Pancreatic cancer (1)
Parkinson's disease (3)
Patents (10)
Patient recruitment (4)
People (1681)
Pharmacy benefit managers (1)
Phase I (806)
Phase II (870)
Phase III (524)
Pipeline (36)
Policy (10)
Postmarket research (25)
Preclinical (271)
Press Release (1)
Prostate cancer (2)
Radiopharmaceuticals (2)
Rare diseases (7)
Real estate (112)
Recruiting (1)
Regulatory (322)
Reports (3)
Research institute (62)
Resumes & cover letters (3)
RSV (1)
Schizophrenia (3)
Series A (9)
Series B (3)
Service/supplier (1)
Special edition (2)
Spinal muscular atrophy (1)
Sponsored (2)
Startups (104)
Supply chain (2)
Tariffs (2)
Vaccines (12)
Weight loss (1)
Date
Today (5)
Last 7 days (31)
Last 30 days (90)
Last 365 days (931)
2025 (333)
2024 (1024)
2023 (1261)
2022 (1594)
2021 (1624)
2020 (1242)
2019 (731)
2018 (540)
2017 (661)
2016 (546)
2015 (591)
2014 (397)
2013 (339)
2012 (292)
2011 (296)
2010 (310)
Location
Africa (14)
Asia (1068)
Australia (89)
California (293)
Canada (79)
China (20)
Colorado (2)
Connecticut (8)
Delaware (5)
Europe (1264)
Florida (18)
Idaho (1)
Illinois (5)
India (1)
Indiana (1)
Japan (5)
Maryland (48)
Massachusetts (130)
Michigan (2)
Minnesota (4)
New Jersey (47)
New Mexico (1)
New York (23)
North Carolina (14)
Northern California (110)
Oklahoma (1)
Pennsylvania (48)
South America (9)
Southern California (107)
Texas (22)
United States (674)
Utah (2)
Washington D.C. (2)
Washington State (10)
Wisconsin (1)
13,101 Results for "calidi biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Calidi Biotherapeutics Announces FDA Clearance of IND Application for CLD-201 in Solid Tumors
April 17, 2025
·
4 min read
Press Releases
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24
April 22, 2025
·
4 min read
Press Releases
Calidi Biotherapeutics Announces Chief Executive Officer Transition and Appointment of Eric Poma, Ph.D. as CEO and Director
April 23, 2025
·
5 min read
Press Releases
Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor
April 10, 2025
·
5 min read
Press Releases
Calidi Biotherapeutics Announces IL15 Superagonist as First Payload to be Delivered by Systemic Antitumor Virotherapy Platform at AACR Annual Meeting
April 28, 2025
·
5 min read
Press Releases
Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 - April 25, 2025
April 28, 2025
·
3 min read
Press Releases
Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement
April 1, 2025
·
5 min read
Press Releases
Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement
March 31, 2025
·
6 min read
Press Releases
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Operational Highlights
April 1, 2025
·
9 min read
Biotech Beach
Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi’s Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors
Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”) today announced that it entered into a collaboration agreement with SIGA Technologies (Nasdaq: SIGA) in the first quarter of 2024, to support the development of Calidi’s systemic and targeted RTNova (CLD-400) virotherapy platform, which has the potential to provide a universal treatment for all tumor types.
June 10, 2024
·
6 min read
1 of 1,311
Next
